Association of Apolipoprotein B-48 Level and Large arterY Atherosclerotic iSchemic Stroke(ABYSS)
NCT01233986 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 112
Last updated 2011-10-05
Summary
The purpose of this study is to evaluate whether the serum apoB48 level is associated with atherosclerotic ischemic stroke.
Conditions
- Acute Ischemic Stroke
Sponsors & Collaborators
-
Hallym University Medical Center
lead OTHER
Principal Investigators
-
Byung-Chul Lee, MD,PhD · Hallym University Medical Center
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2011-03-31
- Completion
- 2011-10-31
Countries
- South Korea
Study Locations
More Related Trials
-
Abciximab in Wake-up Stroke
NCT00167765 ·Status: TERMINATED ·Phase: PHASE3
-
BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis
NCT07237308 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation
NCT06864052 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke
NCT04813445 ·Status: UNKNOWN ·Phase: NA
-
Apixaban for Treatment of Embolic Stroke of Undetermined Source
NCT02427126 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.
NCT04304508 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke
NCT01684462 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase I Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of AAPB for Injection
NCT06679998 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
NCT07333950 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke
NCT01273935 ·Status: COMPLETED
-
Identification of Biomarkers in Ischemic Stroke - Clinical Trial
NCT04253275 ·Status: COMPLETED ·Phase: NA
-
Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
NCT03394950 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke
NCT01790997 ·Status: COMPLETED ·Phase: PHASE3
-
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
NCT06226805 ·Status: RECRUITING ·Phase: PHASE2
-
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
NCT05032053 ·Status: RECRUITING
-
Efficacy of BNG-1 to Treat Acute Ischemic Stroke
NCT01675115 ·Status: COMPLETED ·Phase: PHASE3
-
The Benefit of Add On DLBS1033 for Ischemic Stroke Patient
NCT04425590 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients
NCT06653946 ·Status: RECRUITING ·Phase: PHASE4
-
Intensive Blood Pressure Intervention in Stroke (IBIS) Trial
NCT03585595 ·Status: WITHDRAWN ·Phase: PHASE3
-
Butylphthalide for Long-term Efficacy in Minor Stroke Study
NCT07230587 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)
NCT00073372 ·Status: TERMINATED ·Phase: PHASE3
-
The Metabolism Research of KLK Treating Acute Cerebral Ischemic Stroke: Focus on Drug Frequency-Efficacy Relationship
NCT02806128 ·Status: UNKNOWN ·Phase: NA
-
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
NCT02549846 ·Status: COMPLETED ·Phase: PHASE4
-
Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease
NCT02953405 ·Status: UNKNOWN
-
Standard Medical Management in Secondary Prevention of Ischemic Stroke in China
NCT00664846 ·Status: COMPLETED ·Phase: NA